oseltamivir has been researched along with Sepsis in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Aires, L; Alisson-Silva, F; Amaral, FC; Antônia, J; Báfica, A; Barroso, SPC; Burgel, PR; Chollet-Martin, S; Costa, VV; Cunha, FQ; de Oliveira Formiga, R; de Souza, FRO; Faria, LF; Fonseca, FR; Heck, N; Hurtado-Nedelec, MM; Lorenzini, CB; Macauley, MS; Mansur, DS; Martin, C; Maurici, R; Mendes, DAGB; Morrot, A; Natale, CC; Paula, NM; Queiroz-Junior, CM; Rocha, EL; Santos, AA; Santos, FRS; Silva, PCS; Sordi, R; Souza, CF; Spiller, F; Starick, MR; Van Weyenbergh, J; Wanderley, CWS; Witko-Sarsat, V | 1 |
Agarwal, A; Agarwal, S; Bhandari, S; Mehta, S; Nawal, CL; Rathore, M; Sharma, R | 1 |
Felderhoff-Müser, U; Göpel, W; Härtel, C; Heitmann, F; Hoehn, T; Keller, M; Roggendorf, M; Ross, S; Stein, A | 1 |
Barquilla, E; Iribarren, JA; Knobel, H; López-Aldeguer, J; Lozano, F; Santos, J; Valencia, E | 1 |
4 other study(ies) available for oseltamivir and Sepsis
Article | Year |
---|---|
Neuraminidase is a host-directed approach to regulate neutrophil responses in sepsis and COVID-19.
Topics: Animals; COVID-19; Humans; Lipopolysaccharides; Matrix Metalloproteinase 9; Mice; Neuraminidase; Neutrophils; Oseltamivir; Reactive Oxygen Species; Sepsis; Zanamivir | 2023 |
Profiling the Mortality due to Influenza A (H1N1) pdm09 at a Tertiary Care Hospital in Jaipur during the Current Season--January & February 2015.
Topics: Adolescent; Adult; Age Factors; Aged; Antiviral Agents; Disease Progression; Female; Hospital Mortality; Hospitalization; Humans; India; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Oseltamivir; Pneumonia, Viral; Risk Factors; Sepsis; Sex Factors; Tertiary Care Centers; Time Factors; Young Adult | 2015 |
Pandemic A/H1N1(2009) influenza infections in very-low-birth-weight infants--a case series from the German Neonatal Network.
Topics: Antiviral Agents; Cause of Death; Cross Infection; Diagnosis, Differential; Female; Germany; Gestational Age; Humans; Infant, Extremely Low Birth Weight; Infant, Newborn; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Oseltamivir; Pneumonia, Viral; Respiratory Distress Syndrome, Newborn; Risk Factors; Sepsis; Survival Rate | 2011 |
Outcomes in HIV-infected patients admitted due to pandemic influenza.
Topics: Adult; Anti-HIV Agents; Antiviral Agents; CD4 Lymphocyte Count; Cohort Studies; Comorbidity; Female; HIV Infections; Hospital Mortality; Humans; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Influenza, Human; Inpatients; Intensive Care Units; Length of Stay; Male; Middle Aged; Obesity; Oseltamivir; Pandemics; Respiratory Tract Diseases; Sepsis; Smoking; Spain; Symptom Assessment; Treatment Outcome; Vaccination | 2012 |